Bakrieland Development Tbk. vs Champion Pacific Indonesia Tbk. — how do they compare? Bakrieland Development Tbk. trades at Rp22 (market cap 1T, 28.75M 24h volume), while Champion Pacific Indonesia Tbk. trades at Rp414 (market cap 384.1B, 16.2K 24h volume). The key difference: Bakrieland Development Tbk. is far larger — about 2.6× Champion Pacific Indonesia Tbk.'s market cap, and Bakrieland Development Tbk. is more actively traded (28.75M versus 16.2K). Which is the better fit depends on your goals.
| ELTY | IGAR | |
|---|---|---|
Market Cap | 1T | 384.1B |
Volume | 28.75M | 16.2K |
Lot | 287.49K | 162 |
Turnover | 638.29M | 6.65M |
Average Price | 22.2 | 410.64 |
Value | 638.29M | 6.65M |
Indicative Equilibrium Price | 22 | 414 |
Indicative Equilibrium Volume | 65.62K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bakrieland Development Tbk. (“The Company”) was established with Notarial Deed No. 209 of John Leonard Waworuntu, S.H., dated June 12, 1990. The Company's articles of association have been amended several times, among others, the changes of the Company's name from PT Elang Realty (formerly PT. Purilestari Indah Pratama) Tbk. to PT Bakrieland Development Tbk. which have been notarized by Notarial Deed No. 29 of Harun Kamil, S.H., dated April 3, 1997.
Read more on ELTY →PT Champion Pacific Indonesia Tbk (The Company) formerly PT Kageo Igar Jaya was established under the name of PT Igar Jaya based on Notarial deed No. 195 dated October 30, 1975, of Mohamad Said Tadjoedin, SH, Notary in Jakarta. Igar Jaya was founded in October 1975 in the Republic of Indonesia as a joint venture with Owens-Illinois, a leading glass container manufacturer in the United States, initially in the production of glass vial and ampoules to support Indonesia’s pharmaceutical industry. However since 1987, due to customer demand, the Company has expanded to the business of plastic, aluminum foil (flexible packaging) and paper folding carton packaging products as well as disposable syringe not only to meet the needs of Indonesia’s pharmaceutical industry but also its cosmetic and food industries. In 1988, the Company relinquished its joint venture status with a view to entering the global market and today has customers in 14 countries outside Indonesia. These include: Britain, Bangladesh, Canada, Guinea, Malaysia, Mauritius, Pakistan, the Philippines, Saudi Arabia, Singapore, Thailand, Trinidad & Tobago, the United States and Zaire.
Read more on IGAR →